Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of BG2109 for endometriosis-associated pain in Chinese patients
CTR20230985Phase 3Terminated
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of linzagolix in endometriosis, sponsored by Kissei Pharmaceutical Co., Ltd.. Started Jul 2023; status: terminated.
02
Drugs
linzagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on CTR20230985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230985.